The androgen metabolite, 5α-Androstane-3β,17β-diol (3β-Diol), activates the oxytocin promoter through an estrogen receptor-β pathway

Endocrinology

Volumn 154, Issue 5, 2013, Pages 1802-1812

  Hiroi, Ryoko ^a   Lacagnina, Anthony F ^a   Hinds, Laura R ^a   Carbone, David G ^a   Uht, Rosalie M ^b   Handa, Robert J ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 ALPHA ANDROSTANE 3 BETA, 17 BETA DIOL; ANDROGEN; ESTRADIOL BENZOATE; ESTROGEN RECEPTOR BETA; LUCIFERASE; MESSENGER RNA; OXYTOCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HORMONE RESPONSIVE ELEMENT; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANDROGENS; ANDROSTANE-3,17-DIOL; ANIMALS; CELLS, CULTURED; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; MICE; OVARIECTOMY; OXYTOCIN; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 84876761292     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-2253     Document Type: Article

References (60)

1. Gaskin JH, Kitay JI. Adrenocortical function in the hamster. Sex differences and effects of gonadal hormones. Endocrinology. 1970; 87:779-786.
2. Handa RJ, Burgess LH, Kerr JE, O'Keefe JA. Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitaryadrenal axis. Horm Behav. 1994;28:464-476.
3. Lund TD, Munson DJ, Haldy ME, Handa RJ. Androgen inhibits, while oestrogen enhances, restraint-induced activation of neuropeptide neurones in the paraventricular nucleus of the hypothalamus. J Neuroendocrinol. 2004;16:272-278.
4. Bingaman EW, Baeckman LM, Yracheta JM, Handa RJ, Gray TS. Localization of androgen receptor within peptidergic neurons of the rat forebrain. Brain Res Bull. 1994;35:379-382.
5. Bingham B, Myung C, Innala L, Gray M, Anonuevo A, Viau V. Androgen receptors in the posterior bed nucleus of the stria terminalis increase neuropeptide expression and the stress-induced activation of the paraventricular nucleus of the hypothalamus. Neuropsychopharmacology. 2011;36:1433-1443.
6. Williamson M, Bingham B, Gray M, Innala L, Viau V. The medial preoptic nucleus integrates the central influences of testosterone on the paraventricular nucleus of the hypothalamus and its extended circuitries. J Neurosci. 2010;30:11762-11770.
7. Lund TD, Hinds LR, Handa RJ. The androgen 5-dihydrotestosterone and its metabolite 5-Androstan-3+,17-diol inhibit the hypothalamo-pituitary-Adrenal response to stress by acting through estrogen receptor-expressing neurons in the hypothalamus. J Neurosci. 2006;26:1448-1456.
8. Gangloff A, Shi R, Nahoum V, Lin SX. Pseudo-symmetry of C19 steroids, alternative binding orientations, and multispecificity in human estrogenic 17-hydroxysteroid dehydrogenase. FASEB J. 2003;17:274-276.
9. Jin Y, Penning TM. Steroid 5-reductases and 3-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism. Best Pract Res Clin Endocrinol Metab. 2001;15:79-94.
10. Steckelbroeck S, Jin Y, Gopishetty S, Oyesanmi B, Penning TM. Human cytosolic 3-hydroxysteroid dehydrogenases of the aldoketo reductase superfamily display significant 3-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. J Biol Chem. 2004;279:10784-10795.
11. Torn S, Nokelainen P, Kurkela R, et al. Production, purification, and functional analysis of recombinant human and mouse 17-hydroxysteroid dehydrogenase type 7. Biochem Biophys Res Commun. 2003;305:37-45.
12. Guerini V, Sau D, Scaccianoce E, et al. The androgen derivative 5-Androstane-3+,17-diol inhibits prostate cancer cell migration through activation of the estrogen receptor-subtype. Cancer Res. 2005;65:5445-5453.
13. Kuiper GG, Shughrue PJ, Merchenthaler I, Gustafsson JA. The estrogen receptor-subtype: a novel mediator of estrogen action in neuroendocrine systems. Front Neuroendocrinol. 1998;19:253-286.
14. Oliveira AG, Coelho PH, Guedes FD, Mahecha GA, Hess RA, Oliveira CA. 5-Androstane-3+,17-diol (3-diol), an estrogenic metabolite of 5-dihydrotestosterone, is a potent modulator of estrogen receptor ER-expression in the ventral prostrate of adult rats. Steroids. 2007;72:914-922.
15. Weihua Z, Lathe R, Warner M, Gustafsson JA. An endocrine pathway in the prostate, ER-, AR, 5-Androstane-3+,17-diol, and CYP7B1, regulates prostate growth. Proc Natl Acad Sci U S A. 2002;99:13589-13594.
16. Alves SE, Lopez V, McEwen BS, Weiland NG. Differential colocalization of estrogen receptor-(ER-) with oxytocin and vasopressin in the paraventricular and supraoptic nuclei of the female rat brain: an immunocytochemical study. Proc Natl Acad Sci U S A. 1998; 95:3281-3286.
17. Hrabovszky E, Kallo I, Hajszan T, Shughrue PJ, Merchenthaler I, Liposits Z. Expression of estrogen receptor-α messenger ribonucleic acid in oxytocin and vasopressin neurons of the rat supraoptic and paraventricular nuclei. Endocrinology. 1998;139:2600-2604.
18. Suzuki S, Handa RJ. Estrogen receptor-α, but not estrogen receptor-, is expressed in prolactin neurons of the female rat paraventricular and supraoptic nuclei: comparison with other neuropeptides. J Comp Neurol. 2005;484:28-42.
19. Nomura M, McKenna E, Korach KS, Pfaff DW, Ogawa S. Estrogen receptor-α regulates transcript levels for oxytocin and arginine vasopressin in the hypothalamic paraventricular nucleus of male mice. Brain Res Mol Brain Res. 2002;109:84-94.
20. PatisaulHB,ScordalakesEM,YoungLJ, Rissman EF. Oxytocin, but not oxytocin receptor, is regulated by oestrogen receptor-in the female mouse hypothalamus. J Neuroendocrinol. 2003;15:787-793.
21. Amico JA, Crowley RS, Insel TR, Thomas A, O'Keefe JA. Effect of gonadal steroids upon hypothalamic oxytocin expression. Adv Exp Med Biol. 1995;395:23-35.
22. Blyth BJ, Hollingshead DJ, Amico JA. Time course of induction of oxytocin messenger ribonucleic acid levels in the hypothalamic paraventricular nucleus of ovariectomized rats following gonadal steroid administration. Life Sci. 1997;60:2427-2433.
23. Shughrue PJ, Dellovade TL, Merchenthaler I. Estrogen modulates oxytocin gene expression in regions of the rat supraoptic and paraventricular nuclei that contain estrogen receptor-α. Prog Brain Res. 2002;139:15-29.
24. Thomas A, Amico JA. Sequential estrogen and progesterone (P) followed by P withdrawal increases the level of oxytocin messenger ribonucleic acid in the hypothalamic paraventricular nucleus of the male rat. Life Sci. 1996;58:1615-1620.
25. Thomas A, Crowley RS, Amico JA. Effect of progesterone on hypothalamic oxytocin messenger ribonucleic acid levels in the lactating rat. Endocrinology. 1995;136:4188-4194.
26. Sharma D, Handa RJ, Uht RM. The ER-ligand 5-Androstane, 3+,17-diol (3-diol) regulates hypothalamic oxytocin (Oxt) gene expression. Endocrinology. 2012;153:2353-2361.
27. Burbach JP, Adan RA, Tol HH, et al. Regulation of the rat oxytocin gene by estradiol. J Neuroendocrinol. 1990;2:633-639.
28. Stedronsky K, Telgmann R, Tillmann G, Walther N, Ivell R. The affinity and activity of the multiple hormone response element in the proximal promoter of the human oxytocin gene. J Neuroendocrinol. 2002;14:472-485.
29. Adan RA, Cox JJ, Beischlag TV, Burbach JP. A composite hormone response element mediates the transactivation of the rat oxytocin gene by different classes of nuclear hormone receptors. Mol Endocrinol. 1993;7:47-57.
30. OsterlundMK,Gustafsson JA, Keller E,HurdYL. Estrogen receptor-(ER-) messenger ribonucleic acid (mRNA) expression within the human forebrain: distinct distribution pattern toER-mRNA.J Clin Endocrinol Metab. 2000;85:3840-3846.
31. Hrabovszky E, Kallo I, Steinhauser A, et al. Estrogen receptor-α in oxytocin and vasopressin neurons of the rat and human hypothalamus: Immunocytochemical and in situ hybridization studies. J Comp Neurol. 2004;473:315-333.
32. Handa RJ, Pak TR, Kudwa AE, Lund TD, Hinds L. An alternate pathway for androgen regulation of brain function: activation of estrogen receptor-by the metabolite of dihydrotestosterone, 5-Androstane-3+,17-diol. Horm Behav. 2008;53:741-752.
33. LundTD,Rovis T, ChungWC,HandaRJ. Novel actions of estrogen receptor-α on anxiety-related behaviors. Endocrinology. 2005;146: 797-807.
34. Windle RJ, Shanks N, Lightman SL, Ingram CD. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology. 1997;138:2829-2834.
35. Pak TR, Chung WC, Hinds LR, Handa RJ. Arginine vasopressin regulation in pre-And postpubertal male rats by the androgen metabolite 3-diol. Am J Physiol Endocrinol Metab. 2009;296: E1409-E1413.
36. Carbone DL, Zuloaga DG, Hiroi R, Foradori CD, Legare ME, Handa RJ. Prenatal dexamethasone exposure potentiates diet-induced hepatosteatosis and decreases plasma IGF-I in a sex-specific fashion. Endocrinology. 2012;153:295-306.
37. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
38. Paxinos G, Watson C. The rat brain in stereotaxic coordinates.New York, NY: Academic Press; 1998.
39. Pak TR, ChungWC,Lund TD, Hinds LR, ClayCM,Handa RJ. The androgen metabolite, 5-Androstane-3+,17-diol, is a potent modulator of estrogen receptor-α1-mediated gene transcription in neuronal cells. Endocrinology. 2005;146:147-155.
40. Weiser MJ, Wu TJ, Handa RJ. Estrogen receptor-α agonist diarylpropionitrile: biological activities of R-And S-enantiomers on behavior and hormonal response to stress. Endocrinology. 2009;150: 1817-1825.
41. Behl C, Widmann M, Trapp T, Holsboer F. 17-α-Estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun. 1995;216:473-482.
42. Green PS, Gridley KE, Simpkins JW. Nuclear estrogen receptorindependent neuroprotection by estratrienes: a novel interaction with glutathione. Neuroscience. 1998;84:7-10.
43. Kim H, Bang OY, Jung MW, et al. Neuroprotective effects of estrogen against -Amyloid toxicity are mediated by estrogen receptors in cultured neuronal cells. Neurosci Lett. 2001;302:58-62.
44. Fleming JG, Spencer TE, Safe SH, Bazer FW. Estrogen regulates transcription of the ovine oxytocin receptor gene through GC-rich SP1 promoter elements. Endocrinology. 2006;147:899-911.
45. Safe S. Transcriptional activation of genes by 17-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm. 2001;62:231-252.
46. Handa RJ, Weiser MJ, Zuloaga DG. A role for the androgen metabolite, 5-Androstane-3+,17-diol, in modulating oestrogen receptor -mediated regulation of hormonal stress reactivity. J Neuroendocrinol. 2009;21:351-358.
47. Saijo K, Collier JG, Li AC, Katzenellenbogen JA, Glass CK. An ADIOL-ER-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell. 2011;145:584-595.
48. Ochedalski T, Subburaju S, Wynn PC, Aguilera G. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-Adrenal axis activity. J Neuroendocrinol. 2007;19:189-197.
49. Windle RJ, Gamble LE, Kershaw YM, Wood SA, Lightman SL, Ingram CD. Gonadal steroid modulation of stress-induced hypothalamo-pituitary-Adrenal activity and anxiety behavior: role of central oxytocin. Endocrinology. 2006;147:2423-2431.
50. Windle RJ, Kershaw YM, Shanks N, Wood SA, Lightman SL, Ingram CD. Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-Adrenal activity. J Neurosci. 2004;24:2974-2982.
51. Crowley RS, Insel TR, O'Keefe JA, Kim NB, Amico JA. Increased accumulation of oxytocin messenger ribonucleic acid in the hypothalamus of the female rat: induction by long term estradiol and progesterone administration and subsequent progesterone withdrawal. Endocrinology. 1995;136:224-231.
52. Chung SK, McCabe JT, Pfaff DW. Estrogen influences on oxytocin mRNA expression in preoptic and anterior hypothalamic regions studied by in situ hybridization. J Comp Neurol. 1991;307:281-295.
53. Koohi MK, Ivell R, Walther N. Transcriptional activation of the oxytocin promoter by oestrogens uses a novel non-classical mechanism of oestrogen receptor action. J Neuroendocrinol. 2005;17: 197-207.
54. Koohi MK, Walther N, Ivell R. A novel molecular assay to discriminate transcriptional effects caused by xenoestrogens. Mol Cell Endocrinol. 2007;276:45-54.
55. Richard S, Zingg HH. The human oxytocin gene promoter is regulated by estrogens. J Biol Chem. 1990;265:6098-6103.
56. Adan RA, Burbach JP. Regulation of vasopressin and oxytocin gene expression by estrogen and thyroid hormone. Prog Brain Res. 1992; 92:127-136.
57. Richard S, Zingg HH. Identification of cis-Acting regulatory elements in the human oxytocin gene promoter. Mol Cell Neurosci. 1991;2:501-510.
58. Belsham DD, Cai F, Cui H, Smukler SR, Salapatek AM, Shkreta L. Generation of a phenotypic array of hypothalamic neuronal cell models to study complex neuroendocrine disorders. Endocrinology. 2004;145:393-400.
59. Miller L, Foradori CD, Lalmansingh AS, Sharma D, Handa RJ, Uht RM. Histone deacetylase 1 (HDAC1) participates in the down-regulation of corticotropin releasing hormone gene (crh) expression. Physiol Behav. 2011;104:312-320.
60. Osterlund MK, Grandien K, Keller E, Hurd YL. The human brain has distinct regional expression patterns of estrogen receptor-mRNA isoforms derived from alternative promoters. J Neurochem. 2000;75:1390-1397.